Avillion Life Sciences

Accelerating global drug development through successful partnering for patient benefit

General Information
Company Name
Avillion Life Sciences
Founded Year
2013
Location (Offices)
London, United Kingdom +1
Founders / Decision Makers
Number of Employees
26
Industries
Health Care, Health and Wellness, Pharmaceutical
Funding Stage
Series Unknown
Social Media

Avillion Life Sciences - Company Profile

A drug development company with an innovative model for Clinical Development. We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.

Taxonomy: drug development, clinical co-development, therapeutics, EU approval, US approval, market acceleration, late-phase projects, patient benefit, innovative model, London-based, partnering, global drug development, successful partnering, Avillion LLP

Funding Rounds & Investors of Avillion Life Sciences (1)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round Unknown 2 Clarus Ventures 28 Jan 2013

Latest News of Avillion Life Sciences

View All

No recent news or press coverage available for Avillion Life Sciences.

Similar Companies to Avillion Life Sciences

View All
Camargo Pharmaceutical Services - Similar company to Avillion Life Sciences
Camargo Pharmaceutical Services Offering specialized comprehensive drug development services tailored for the 505(b)(2) approval pathway and similar European processes.
ResQ Pharma - Similar company to Avillion Life Sciences
ResQ Pharma Revolutionizing overdose treatment with proven lipid emulsion therapy
TMC Pharma Services Ltd - Similar company to Avillion Life Sciences
TMC Pharma Services Ltd Combining traditional CRO services with full support for all activities in the pre-, peri- and post-marketing setting
Novel351k - Similar company to Avillion Life Sciences
Novel351k Global solutions for accessible biosimilars.